Mcl1-IN-2 is primarily utilized in research settings as a potent inhibitor of Mcl-1, a protein involved in the regulation of apoptosis. Its application is significant in the study of cancer biology, particularly in understanding the role of Mcl-1 in cancer cell survival and resistance to chemotherapy. Researchers use this compound to explore potential therapeutic strategies for cancers that overexpress Mcl-1, such as certain types of leukemia, lymphoma, and solid tumors. By inhibiting Mcl-1, it helps in promoting apoptosis in cancer cells, making it a valuable tool in preclinical studies aimed at developing targeted cancer therapies. Additionally, it aids in investigating the mechanisms of drug resistance and identifying combination treatments that enhance the efficacy of existing anticancer drugs.